
Quarterly report 2024-Q1
added 05-06-2024
ShockWave Medical Net Debt 2011-2026 | SWAV
Net Debt can be roughly defined as financial liabilities that an entity classifies in the financing section together with the resources available to service those financial liabilities[1]
Net debt is the obligations that remain after deducting all assets and other liabilities from a company or individual. It represents the sum of debts that an organization or person must repay to their creditors or other parties.
Net debt can include various types of obligations such as loans, borrowings, lease liabilities, or credit card payments. It is important to note that net debt does not include current expenses or obligations such as payroll expenses or current bills.
Assessing net debt is an important financial indicator for evaluating the financial position of a company or individual. If net debt significantly exceeds assets, it may indicate financial difficulties and insolvency. In such cases, the company or individual may face difficulties in meeting their obligations and managing their finances.
Net debt can also be used to compare the financial stability of different companies. The lower the net debt relative to assets, the more stable and financially sound they are considered.
Overall, understanding net debt helps evaluate the financial soundness and ability of a company to meet their obligations. It is an important indicator that assists in making decisions about lending, investments, and financial management.
Annual Net Debt ShockWave Medical
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 407 M | -131 M | -77.5 M | -43.5 M | -125 M | -24.6 M | -51.9 M | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 407 M | -131 M | -6.68 M |
References
- Pizzo, M., Moscariello, N., & Vinciguerra, R. (2015). Market Incentives and Regulators' Activity Shaping Financial Information: An Analysis of the Net Debt Disclosure in Italy. International Journal of Business and Management, 10(1), 1.
Net Debt of other stocks in the Medical devices industry
| Issuer | Net Debt | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Boston Scientific Corporation
BSX
|
9.26 B | $ 62.59 | -0.37 % | $ 92.7 B | ||
|
AdaptHealth Corp.
AHCO
|
1.64 B | $ 12.07 | 0.33 % | $ 1.63 B | ||
|
Cytosorbents Corporation
CTSO
|
11 M | $ 0.59 | 1.2 % | $ 36.7 M | ||
|
GenMark Diagnostics, Inc.
GNMK
|
38.7 M | - | - | $ 1.77 B | ||
|
Delcath Systems
DCTH
|
-42.5 M | $ 9.7 | 0.73 % | $ 347 M | ||
|
Apollo Endosurgery
APEN
|
-22.5 M | - | - | $ 475 M | ||
|
Acutus Medical
AFIB
|
14.2 M | - | -26.83 % | $ 2.62 M | ||
|
Avinger
AVGR
|
-16.3 M | - | -20.74 % | $ 369 K | ||
|
Axonics Modulation Technologies
AXNX
|
-230 M | - | - | $ 3.31 B | ||
|
Aziyo Biologics
AZYO
|
-32.4 M | - | 1.37 % | $ 20.5 M | ||
|
Allied Healthcare Products
AHPI
|
-3.31 M | - | 3.58 % | $ 2.21 M | ||
|
EDAP TMS S.A.
EDAP
|
-22.8 M | $ 3.45 | 1.77 % | $ 129 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
6.46 M | - | -5.86 % | $ 30.6 M | ||
|
Edwards Lifesciences Corporation
EW
|
-2.32 B | $ 81.19 | 0.17 % | $ 47.5 B | ||
|
BioSig Technologies
BSGM
|
252 K | - | 37.08 % | $ 85.7 M | ||
|
FONAR Corporation
FONR
|
-42.8 M | $ 18.6 | 0.05 % | $ 122 M | ||
|
Butterfly Network
BFLY
|
-65.9 M | $ 4.13 | 0.49 % | $ 874 M | ||
|
Cardiovascular Systems
CSII
|
-64.6 M | - | 0.15 % | $ 844 M | ||
|
Bruker Corporation
BRKR
|
1.91 B | $ 36.74 | -0.05 % | $ 5.47 K | ||
|
Cutera
CUTR
|
-140 M | - | -10.19 % | $ 1.99 M | ||
|
AxoGen
AXGN
|
15.2 M | $ 32.64 | -5.23 % | $ 1.5 B | ||
|
Helius Medical Technologies
HSDT
|
-5.12 M | $ 1.9 | 2.15 % | $ 1.15 M | ||
|
Integra LifeSciences Holdings Corporation
IART
|
529 M | $ 9.31 | -2.31 % | $ 717 M | ||
|
Inogen
INGN
|
-86.3 M | $ 6.36 | 2.42 % | $ 169 M | ||
|
CryoLife, Inc.
CRY
|
230 M | - | -4.14 % | $ 702 M | ||
|
IRIDEX Corporation
IRIX
|
-5.23 M | $ 1.0 | 1.66 % | $ 16.9 M | ||
|
IRadimed Corporation
IRMD
|
-52.1 M | $ 95.66 | -0.59 % | $ 1.22 B | ||
|
Integer Holdings Corporation
ITGR
|
1.18 B | $ 85.63 | -1.4 % | $ 2.97 B | ||
|
Dynatronics Corporation
DYNT
|
1.8 M | - | 14.99 % | $ 929 K | ||
|
Align Technology
ALGN
|
-925 M | $ 171.87 | 0.74 % | $ 12.9 B | ||
|
Eargo
EAR
|
-97.8 M | - | - | $ 10.2 M | ||
|
OrthoPediatrics Corp.
KIDS
|
83.3 M | $ 15.94 | -0.75 % | $ 374 M | ||
|
LENSAR
LNSR
|
-10.2 M | $ 5.89 | -2.81 % | $ 70.4 M | ||
|
Soliton, Inc.
SOLY
|
-31.6 M | - | -1.42 % | $ 435 M | ||
|
ClearPoint Neuro
CLPT
|
3.85 M | $ 9.38 | 0.11 % | $ 266 M | ||
|
Conformis
CFMS
|
-26.2 M | - | - | $ 16.4 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
-9.02 K | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
-2.3 M | - | 0.03 % | $ 1.58 B | ||
|
Pulmonx Corporation
LUNG
|
-31.6 M | $ 1.36 | 2.26 % | $ 55.3 M | ||
|
Misonix, Inc.
MSON
|
5.72 M | - | - | $ 462 M | ||
|
Medtronic PLC
MDT
|
23.6 B | $ 86.28 | -0.4 % | $ 111 B | ||
|
MiMedx Group
MDXG
|
-148 M | $ 3.88 | -1.02 % | $ 573 M | ||
|
Neovasc
NVCN
|
-4.95 M | - | - | $ 111 M | ||
|
Second Sight Medical Products
EYES
|
2.62 M | - | -0.97 % | $ 54.4 M | ||
|
Myomo
MYO
|
-4.79 M | $ 0.7 | 4.84 % | $ 29.3 M | ||
|
Intersect ENT, Inc.
XENT
|
50.8 M | - | - | $ 955 M | ||
|
Orthofix Medical
OFIX
|
78.5 M | $ 11.77 | 2.08 % | $ 466 M | ||
|
PAVmed
PAVM
|
710 K | $ 10.04 | 1.93 % | $ 6.73 M |